Article Text

Download PDFPDF
F16 The progression of pathology in 4 years longitudinally monitored patients with late onset Huntington’s disease
  1. Martina Petracca1,
  2. Paola Zinzi1,2,
  3. Sonia Di Tella3,
  4. Marcella Solito1,4,
  5. Maria Rita Lo Monaco5,6,
  6. Paolo Calabresi1,4,
  7. Maria Caterina Silveri3,5,
  8. Anna Rita Bentivoglio1,4
  1. 1Movement Disorders Unit, Fondazione Policlinico Universitario ‘Agostino Gemelli’ IRCCS, Rome, Italy
  2. 2Clinical Psychology Unit, Fondazione Policlinico Universitario ‘Agostino Gemelli’ IRCCS, Rome, Italy
  3. 3Department of Psychology, Università Cattolica del Sacro Cuore, Milan, Italy
  4. 4Institute of Neurology, Università Cattolica del Sacro Cuore, Rome, Italy
  5. 5Institute of Internal Medicine and Geriatrics, Università Cattolica del Sacro Cuore, Rome, Italy
  6. 6Center for the Medicine of Aging, Fondazione Policlinico Universitario ‘Agostino Gemelli’ IRCSS, Rome, Italy


Despite recent interest in late-onset Huntington’s Disease (LoHD) phenotype, scarce evidence is available regarding it’s progression. This study aimed to investigate changes over time in clinical features in LoHD patients. This is a retrospective observational study on 99 LoHD (motor onset ≥60 years) and 854 patients with common-onset (CoHD, motor onset 30-59 years) from Enroll-HD PDS5, followed-up to 4 years. Linear mixed models were performed to evaluate differences between the two groups and the ‘time’ effect at three different timepoints: t0 (baseline), t1 and t2 (respectively, 2 and 4 years). Body Mass Index (BMI), Total UHDRS Functional Capacity (TFC) &Total Motor Score (TMS), Problem Behaviors Assessment (PBAs), MMSE and a short cognitive battery were examined at each timepoint. The results showed that 50.4% of CoHD patients were males, the mean age at baseline was 52.57±8.96 years, the mean CAGn on mutated allele was 43.50±2.47. LoHD patients were males in 41.4%; baseline mean age was 70.88±4.74 years, and mean CAGn was 40.83±1.31. In CoHD and LoHD, weight remained stable at t1 but significantly decreased at t2; motor performance significantly worsened at t1 and t2, and functionality scores lowered at both timepoints. Significant differences between groups emerged on many cognitive tasks, with LoHD showing less preserved cognitive status. Time effect emerged in most tests, with significant progressive worsening. At PBA-s, depression significantly reduced at t2 while apathy increased. No significant changes were detected in irritability and psychosis over time. In conclusion, the clinical progression of both groups is characterized by worsening in motor and cognitive performance and reduction in functionality over 2 and 4 years. Neuropsychiatric features follow different trajectories along HD course, deserving further exploration.

  • Late onset HD
  • Common Onset HD
  • Longitudinal study
  • disease progression
  • Enroll-HD

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.